Friday, October 16, 2026 · Petrol Rs 390.23 · USD/PKR 277.05 · Gold Rs 437836/tola
Breaking
Case Registered Against Peshawar School Owners After Roof Collapse Kills 31 School Owner Arrested Over Peshawar Roof Collapse KP Orders Structural Checks on Every Government School Federal Constitutional Court Ends Challenge to Afridi’s Appointment Naqvi Calls Direct Rule a Last Resort After Talks Stalled Opposition Alliance Calls Off Talks With the Government DNA Findings Prompt Fresh Scrutiny in Hina Javed Murder Investigation KSE-100 Climbs 769 Points as Rebound Gathers Pace Petrol Cut to Rs390.23 as Diesel Edges Up Again Peshawar High Court to Hear Challenges to KP Governor’s Rule on October 20 Gold Holds at Rs437,836 After Thursday’s Sharp Fall Trump Rules Out Nuclear Weapons Against Iran FBR Extends Income Tax Return Deadline to 31 October Pakistan to Chair IMF and World Bank Governors After 74 Years Nawaz Sharif’s Cars Vandalised in London, CCTV Shows Masked Men IHC Gives PTI More Time to Respond in Case Seeking Ban on Imran Khan’s X Account Drought Drives Thari Herders and Livestock Out of the Desert Two Killed as Landslides, Snowfall Disrupt Travel Across Gilgit-Baltistan Trump Predicts Swift End to Iran War as Tehran Rejects Pressure to Submit IMF Warns Middle East Economies Face Lasting Scars From Regional War

Articles for tag: Alibaba, biotech, BYD, china, CPEC, Electric Vehicles, gwadar, Investment, Pakistan, Pharma, SEZ, Trade

July 5, 2026

Frontpage.dev

The Express Tribune

CPEC 2.0 Moves Into Pharma, EVs and 44 SEZs as Pakistan-China Industrial Cooperation Enters New Phase

Pakistan and China are entering a new phase of CPEC cooperation focused on industrialisation, pharmaceuticals, information technology, and critical minerals — a shift from the infrastructure-heavy first phase toward higher-value economic integration. BYD will begin assembling electric and hybrid vehicles in Pakistan by July-August 2026, and a Pakistan-China pharma and biotech B2B conference is scheduled for Karachi in mid-July.

April 17, 2025

News Desk

Lilly’s weight loss pill shows promise in the middle of Pharma Shakeup: Time

Listen to the article In detailed operation by Time MagazineThe pharmaceutical giant Eli Lilly has revealed promising first results of clinical trials of experimental oral orforglipron, GLP-1-based treatment for diabetes and weight loss. Growth marks a potentially transformative moment for both the company and the landscape of obesity-therapy. The data presented during a critical meeting at Lilly, Indianapolis on April 15, showed that Orforglipron reduced blood sugar levels and helped lose weight without serious side effects, such as hepatic toxicity – a pf. The results of Orforglipron were comparable to Lilly’s Blockbuster Tirzepatide (Mounjaro). If approved by the FDA, Orforglipron

August 17, 2024

News Desk

Plan to create Pharma Economic Zone

Islamabad: The Special Investment Facilitation Council (SIFC) is promoting plans to set up a Pharmaceutical Economic Zone under a public-private partnership (PPP) regime to promote medical tourism and attract investment in the pharmaceutical industry. In addition, it wishes to establish a Medical/Health City as part of the PPP model. Sources told The Express Tribune that the Ministry of National Health Services, Regulation and Coordination had been instructed to discuss the Pharma Economic Zone proposal along with setting up a Medical City, with the participation of relevant stakeholders. These discussions will help identify the right industrial mix and other development avenues

April 18, 2024

News Desk

The pharmaceutical industry needs urgent reforms

LAHORE: The Pakistan Pharmaceutical Manufacturers Association (PPMA) has emphasized the need to update existing drug legislation to align with global trends for the benefit of patients and the pharmaceutical industry. “Local industries are closing due to historically high input costs, higher inflation and bank interest rates in Asia. Multinationals disappear due to excessive regulations. Currently, only four multinational corporations (MNCs) are operating in the country, all of which have recently reported historically high losses,” PPMA Chairman Mian Khalid Misbah said on Wednesday. Addressing the media, he emphasized that the patients are the ultimate sufferers and the situation is getting worse.

October 23, 2022

The Pakistan Daily

Pharma giant stops production of Panadol in Pakistan

ISLAMABAD: Pakistan’s largest pharmaceuticals declared force majeure, a French term that describes uncontrollable events, regarding the production of Panadol, a critical over-the-counter drug. In a filing to the Pakistan Stock Exchange, the Pakistan unit of British multinational pharmaceutical said it has suspended the manufacturing of Panadol Tablets, Panadol Extra Tablets, and Children’s Panadol Liquid Range, maintaining it has become unsustainable to produce the cheap drug citing huge losses. The development comes amid a severe shortage of Panadol in the market across different cities in Pakistan which has only worsened amid a dengue outbreak after deadly floods. The pharma giant, which

Hamza Azhar SalamEditor — Hamza Azhar Salam · Write to us with suggestions or tips
Powered by: Frontpage.dev
WP Twitter Auto Publish Powered By : XYZScripts.com